Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ESHAR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 13
  • 0 comments

ESHAR attributes changed: Attr: Fin_status N -> E;

Comment Full text

CELULARITY INC (CELU)

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 11
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

CELULARITY INC (CELUW)

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 10
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

CELU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 12
  • 0 comments

CELU attributes changed: Attr: Fin_status N -> E;

Comment Full text

CELUW attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 16
  • 0 comments

CELUW attributes changed: Attr: Fin_status N -> E;

Comment Full text

CETY attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 12
  • 0 comments

CETY attributes changed: Attr: Fin_status N -> E;

Comment Full text

BRLS attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 15
  • 0 comments

BRLS attributes changed: Attr: Fin_status D -> H;

Comment Full text

BRLSW attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 14
  • 0 comments

BRLSW attributes changed: Attr: Fin_status D -> H;

Comment Full text

AFJKU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:50 UTC
  • 13
  • 0 comments

AFJKU attributes changed: Attr: Fin_status N -> E;

Comment Full text

AFJKR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:50 UTC
  • 11
  • 0 comments

AFJKR attributes changed: Attr: Fin_status N -> E;

Comment Full text
  • Previous
  • 212
  • 213
  • 214
  • 215
  • 216
  • Next

Search

News categories

  • Technical Exchange News(14165)
  • Event(6229)
  • SEC News(361393)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222200)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin